Clinical Study of Sarjarasa Avachurnan in Ghrushtavrana

An Open Randomized Control Clinical Study of Sarjarasa Avachurnan in Ghrushtavrana - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/104403

Enrollment

Registered

2026-02-20

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: T758- Other specified effects of external causes

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1 Shows symptoms of Sadyovrana- Grushta Vrana (Abrasion) 2 Patients willing to take the treatment with informed consent 3 Wound size up to 5 cm2 to 10 cm2 4 Patient with epidermal dermal and deep abrasion

Exclusion criteria

Exclusion criteria: 1 Patient with infected wound dushta vrana dagdh vrana 2 Patient with known history of DM HIV HBsAG Tuberculosis neurogenic disorder or any other systemic disease 3 Malignant ulcer 4 Patient with burn 5 Ulcer due to varicose veins non healing wound fracture etc 6 Any complication will be excluded

Design outcomes

Primary

Measure	Time frame
Clinical efficacy of Sarjarasa Churna on GhrushtavranaTimepoint: 07 days	—

Secondary

Measure	Time frame
Clinical efficacy of Povidone Iodine Powder 5 percent on GhrushtavranaTimepoint: 07 days	—

Countries

India

Contacts

Public ContactDr Vijay Sarjarao Dange

Hon Shri Annasaheb Dange Ayurved Medical College Post Graduate And Research Center Ashta

drvijaydange@gmail.com8600600181

Outcome results